BREAKING
Agilent Q1 Revenue Rises 7%, Net Income Declines 11 hours ago Synopsys Q1 2026 Earnings Results 13 hours ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 14 hours ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 14 hours ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 2 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 2 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 2 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 2 days ago UnitedHealth Group Incorporated (UNH) Drops 5.8% — Developing Story 2 days ago Accenture plc (ACN) Drops 6.0% — Developing Story 2 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 11 hours ago Synopsys Q1 2026 Earnings Results 13 hours ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 14 hours ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 14 hours ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 2 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 2 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 2 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 2 days ago UnitedHealth Group Incorporated (UNH) Drops 5.8% — Developing Story 2 days ago Accenture plc (ACN) Drops 6.0% — Developing Story 2 days ago
REGN

Regeneron Pharmaceuticals Inc

$REGN NASDAQ Feb 26, 2026 All Day FY 2026

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

REGN Coverage

Event Regeneron Pharmaceuticals Inc (REGN) Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS) Feb 24, 2026 Event Regeneron Pharmaceuticals Inc (REGN) Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP) Feb 19, 2026 Event Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Feb 16, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Transcript Feb 2, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Regeneron Pharmaceuticals Inc (REGN) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7% May 4, 2023 Press Release Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31% Feb 3, 2023